SPY417.26+1.39 0.33%
DIA341.86+1.53 0.45%
IXIC14,052.34+13.58 0.10%

BRIEF-Azurrx Biopharma Announces Completion Of Enrollment In Phase 2B Option 2 Clinical Trial Of Ms1819 In Cystic Fibrosis

· 03/16/2021 07:07
BRIEF-Azurrx Biopharma Announces Completion Of Enrollment In Phase 2B Option 2 Clinical Trial Of Ms1819 In Cystic Fibrosis

- AzurRx BioPharma Inc AZRX.O:

  • AZURRX BIOPHARMA ANNOUNCES COMPLETION OF ENROLLMENT IN PHASE 2B OPTION 2 CLINICAL TRIAL OF MS1819 IN CYSTIC FIBROSIS

  • AZURRX BIOPHARMA INC - TRIAL ENROLLED 30 CF PATIENTS AND TOP LINE DATA FROM STUDY IS ANTICIPATED BY END OF Q1 2021

Source text for Eikon: ID:nGNX6wWBd4

Further company coverage: AZRX.O


((Reuters.Briefs@thomsonreuters.com;))